Mizuho Securities analyst Steven Valiquette has maintained their neutral stance on HSIC stock, giving a Hold rating on January 23.Invest with ...
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...
Securities updated their financial outlook on Henry Schein (NASDAQ:HSIC), increasing the price target to $78 from the previous $75, while maintaining a Neutral rating on the company's stock. According ...
Health-care companies fell amid mixed earnings. Shares of Danaher, which makes tools and equipment for the biotech, life-sciences and diagnostics businesses, plunged by roughly 10% after it posted ...
Fourth-quarter per-share earnings of 80 cents top analysts' estimates of 46 cents. The Spanish bank, which generates most of its income from outside the country, expects growth this year after 2024 ...
Fourth-quarter per-share earnings of 80 cents top analysts' estimates of 46 cents. The Spanish bank, which generates most of its income from outside the country, expects growth this year after 2024 ...
Hosted on MSN23h
Stocks Fall on Hawkish Fed PauseWednesday closed down -0.47%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.31%, and the Nasdaq 100 Index ...
East Coast Asset Management partnered with Eolas Capital to expand into the U.S. market with a new investment vehicle based ...
Petra Capital raises $270 million for fifth growth fund, Northwind Group funds $135 million Pfizer HQ conversion loan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback